To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Ember Therapeutics licenses brown fat protein from Joslin Diabetes Center

By Chris Reidy

 |  Globe Staff  

  March 28, 2012

Ember Therapeutics Inc., a Boston start-up looking to build a portfolio of intellectual property related to brown fat, has completed a licensing agreement with the Joslin Diabetes Center. Joslin researchers have been studying a protein shown to play a role in the regulation of brown fat development. White fat stores energy; brown fat burns it off. Ember believes that proteins regulating brown fat can be used to treat such metabolic diseases as obesity and Type 2 diabetes.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help